Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB 2 in modulating breast cancer growth and invasion

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Nasser, Mohd W ^a   Qamri, Zahida ^a   Deol, Yadwinder S ^a   Smith, Diane ^a   Shilo, Konstantin ^a   Zou, Xianghong ^a   Ganju, Ramesh K ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; CANNABINOID 2 RECEPTOR; CHEMOKINE RECEPTOR CXCR4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P52; UNCLASSIFIED DRUG; INDOLE DERIVATIVE; JHW 015; STROMAL CELL DERIVED FACTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER MODEL; CANCER TISSUE; CELL MIGRATION; CHEMOTAXIS; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; FEMALE; FOCAL ADHESION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; STRESS FIBER; WOUND HEALING; WOUND HEALING ASSAY; ANIMAL; BREAST TUMOR; CELL MOTION; DRUG EFFECT; DRUG POTENTIATION; DRUG SCREENING; FLOW CYTOMETRY; METABOLISM; PHOSPHORYLATION; TUMOR CELL LINE; WESTERN BLOTTING;

MOUSE MAMMARY TUMOR VIRUS; MUS;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CHEMOKINE CXCL12; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; MICE; MICROSCOPY, CONFOCAL; PHOSPHORYLATION; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CXCR4; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80052532033     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023901     Document Type: Article

References (53)

1. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI, (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
2. Munro S, Thomas KL, Abu-Shaar M, (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65.
3. Blazquez C, Carracedo A, Barrado L, Real PJ, Fernandez-Luna JL, et al. (2006) Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 20: 2633-2635.
4. Preet A, Qamri Z, Nasser MW, Prasad A, Shilo K, et al. (2011) Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. Cancer Prev Res (Phila) 4: 65-75.
5. Qamri Z, Preet A, Nasser MW, Bass CE, Leone G, et al. (2009) Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Mol Cancer Ther 8: 3117-3129.
6. Sarfaraz S, Afaq F, Adhami VM, Malik A, Mukhtar H, (2006) Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest. J Biol Chem 281: 39480-39491.
7. Xu X, Liu Y, Huang S, Liu G, Xie C, et al. (2006) Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet 171: 31-38.
8. Jia W, Hegde VL, Singh NP, Sisco D, Grant S, et al. (2006) Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria. Mol Cancer Res 4: 549-562.
9. Kogan NM, Blazquez C, Alvarez L, Gallily R, Schlesinger M, et al. (2006) A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells. Mol Pharmacol 70: 51-59.
10. Carracedo A, Lorente M, Egia A, Blazquez C, Garcia S, et al. (2006) The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells. Cancer Cell 9: 301-312.
11. Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, et al. (2003) Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 111: 43-50.
12. Galve-Roperh I, Sanchez C, Cortes ML, Gomez del Pulgar T, Izquierdo M, et al. (2000) Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med 6: 313-319.
13. Sanchez C, de Ceballos ML, Gomez del Pulgar T, Rueda D, Corbacho C, et al. (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61: 5784-5789.
14. Ellert-Miklaszewska A, Kaminska B, Konarska L, (2005) Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. Cell Signal 17: 25-37.
15. Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, et al. (1998) The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem 273: 23169-23175.
16. Hamm HE, (1998) The many faces of G protein signaling. J Biol Chem 273: 669-672.
17. Balkwill F, (2004) The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14: 171-179.
18. Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, et al. (2004) Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 18: 1240-1242.
19. Muller A, Homey B, Soto H, Ge N, Catron D, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
20. Andre F, Cabioglu N, Assi H, Sabourin JC, Delaloge S, et al. (2006) Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. Ann Oncol 17: 945-951.
21. Blot E, Laberge-Le Couteulx S, Jamali H, Cornic M, Guillemet C, et al. (2008) CXCR4 membrane expression in node-negative breast cancer. Breast J 14: 268-274.
22. Cabioglu N, Gong Y, Islam R, Broglio KR, Sneige N, et al. (2007) Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer. Ann Oncol 18: 1021-1029.
23. Cabioglu N, Sahin A, Doucet M, Yavuz E, Igci A, et al. (2005) Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow. Clin Exp Metastasis 22: 39-46.
24. Cabioglu N, Sahin AA, Morandi P, Meric-Bernstam F, Islam R, et al. (2009) Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications. Ann Oncol 20: 1013-1019.
25. Chu QD, Holm N, Byrnes K, Li BD, (2008) Translational research in breast cancer. Surg Oncol Clin N Am 17: 421-438, x.
26. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
27. Li M, Ransohoff RM, (2009) The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis. Semin Cancer Biol 19: 111-115.
28. Liang Z, Wu T, Lou H, Yu X, Taichman RS, et al. (2004) Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64: 4302-4308.
29. Tamamura H, Fujii N, (2005) The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis. Expert Opin Ther Targets 9: 1267-1282.
30. Tamamura H, Hori A, Kanzaki N, Hiramatsu K, Mizumoto M, et al. (2003) T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer. FEBS Lett 550: 79-83.
31. Fernandis AZ, Prasad A, Band H, Klosel R, Ganju RK, (2004) Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 23: 157-167.
32. Mitra SK, Hanson DA, Schlaepfer DD, (2005) Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 6: 56-68.
33. Albiges-Rizo C, Destaing O, Fourcade B, Planus E, Block MR, (2009) Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions. J Cell Sci 122: 3037-3049.
34. Ueda Y, Neel NF, Schutyser E, Raman D, Richmond A, (2006) Deletion of the COOH-terminal domain of CXC chemokine receptor 4 leads to the down-regulation of cell-to-cell contact, enhanced motility and proliferation in breast carcinoma cells. Cancer Res 66: 5665-5675.
35. Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, et al. (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115: 44-55.
36. Trimboli AJ, Cantemir-Stone CZ, Li F, Wallace JA, Merchant A, et al. (2009) Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 461: 1084-1091.
37. Preet A, Ganju RK, Groopman JE, (2008) Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo. Oncogene 27: 339-346.
38. Bachelder RE, Wendt MA, Mercurio AM, (2002) Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 62: 7203-7206.
39. Ganju RK, Deol YS, Nasser MW, (2011) CXCL12/CXCR4 Signaling Axis: Role in Tumor Progression and Metastasis. In: Fatitis A, editors. Published by Springer Science and Business Media.
40. Weigel MT, Dowsett M, (2010) Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer 17: R245-262.
41. Caffarel MM, Andradas C, Mira E, Perez-Gomez E, Cerutti C, et al. (2010) Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. Mol Cancer 9: 196.
42. Chu QD, Panu L, Holm NT, Li BD, Johnson LW, et al. (2010) High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome. J Surg Res 159: 689-695.
43. Richmond A, Fan GH, Dhawan P, Yang J, (2004) How do chemokine/chemokine receptor activations affect tumorigenesis? Novartis Found Symp 256: 74-89; discussion 89-91, 106-111, 266-109.
44. Ghosh S, Preet A, Groopman JE, Ganju RK, (2006) Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes. Mol Immunol 43: 2169-2179.
45. Bendall LJ, Baraz R, Juarez J, Shen W, Bradstock KF, (2005) Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia. Cancer Res 65: 3290-3298.
46. Helbig G, Christopherson KW 2nd, Bhat-Nakshatri P, Kumar S, Kishimoto H, et al. (2003) NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631-21638.
47. Inngjerdingen M, Torgersen KM, Maghazachi AA, (2002) Lck is required for stromal cell-derived factor 1 alpha (CXCL12)-induced lymphoid cell chemotaxis. Blood 99: 4318-4325.
48. Lee BC, Lee TH, Avraham S, Avraham HK, (2004) Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res 2: 327-338.
49. Zhao M, Mueller BM, DiScipio RG, Schraufstatter IU, (2008) Akt plays an important role in breast cancer cell chemotaxis to CXCL12. Breast Cancer Res Treat 110: 211-222.
50. Teranishi S, Kimura K, Nishida T, (2009) Role of formation of an ERK-FAK-paxillin complex in migration of human corneal epithelial cells during wound closure in vitro. Invest Ophthalmol Vis Sci 50: 5646-5652.
51. Friedl P, Wolf K, (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 3: 362-374.
52. van Nimwegen MJ, Verkoeijen S, van Buren L, Burg D, van de Water B, (2005) Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation. Cancer Res 65: 4698-4706.
53. Sun CK, Man K, Ng KT, Ho JW, Lim ZX, et al. (2008) Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis 29: 2096-2105.